
    
      The primary objective of this PAS is to assure the continued safety and effectiveness of the
      Tryton Side Branch Stent™ with main branch approved DES in the treatment of de novo native
      coronary artery bifurcation lesions with side branch diameter ranging from ≥2.5 mm to ≤3.5 mm
      and main branch diameter ranging from ≥2.5 mm to ≤4.0 mm.
    
  